Anne Wojcicki Reclaims Control of 23andMe

Anne Wojcicki Reclaims Control of 23andMe

Recent Developments in the 23andMe Acquisition Saga

In an unexpected development, Anne Wojcicki, who founded 23andMe, is on the path to reclaim leadership of the DNA testing company. Previously, Regeneron had acquired the company for $256 million through a bankruptcy auction. However, Wojcicki’s nonprofit entity, TTAM Research Institute, made an unexpected counteroffer of $305 million.

The situation led to the reopening of bids under the condition set by a bankruptcy judge, which required Regeneron to surpass TTAM's bid by a minimum of $10 million. Regeneron opted not to increase their bid, resulting in a potential agreement where TTAM might take over, pending judicial approval. This decisive hearing is scheduled for June 17, 2025.

Plans and Protections Moving Forward

Regeneron had initially intended to retain the current workforce and persist in selling DNA testing kits to consumers. The data derived from these kits holds dual importance: helping individuals explore their genetic heritage and offering valuable insights into potential health issues. For Regeneron, these insights were seen as a potential asset in drug development.

Wojcicki’s long-term plans for 23andMe are not entirely clear, but the company has pledged various data privacy measures. TTAM has committed to allowing customers to withdraw from data collection initiatives and erase their personal data. They also plan to establish a Consumer Privacy Advocacy Board. Moreover, in the event of another bankruptcy scenario, TTAM has promised not to sell user genetic data unless the purchasing entity agrees to uphold these privacy measures.

A Return to Familiar Leadership

Wojcicki had been strategizing to regain control of 23andMe since the company filed for bankruptcy in March 2025. To facilitate her bid, she stepped down from her role as CEO. Her motivation is clear: she has always intended for the company to empower individuals by giving them access and understanding of their genetic information.

"My enthusiasm is boundless with TTAM Research Institute poised to further 23andMe's mission—enabling people to understand and gain the benefits from the human genome," Wojcicki remarked. "It is vital that people have the power to make informed choices and understand their genetic data, allowing them to explore their ancestry and health risks as they please."

The Challenges Leading to Bankruptcy

23andMe faced significant hurdles before it declared bankruptcy. The company endured a substantial data breach in 2023 that compromised the information of millions of users. This was followed by massive layoffs in 2024, with nearly 40% of the workforce being affected.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts